Core Insights - UnitedHealth Group Incorporated (UNH) has a market capitalization of $265.6 billion and operates organized health systems, providing employee benefit programs globally [1] Performance Overview - UNH shares have underperformed the broader market, declining 44.8% over the past year, while the S&P 500 Index has increased by nearly 11.8% [2] - In 2026, UNH's stock fell 11.2%, contrasting with a slight dip in the S&P 500 on a year-to-date basis [2] - Compared to the iShares U.S. Healthcare Providers ETF (IHF), which declined about 12.1% over the past year and 3.5% year-to-date, UNH's underperformance is evident [3] Financial Results - On January 27, UNH shares dropped 19.6% following the release of fiscal 2025 Q4 results, where revenue increased by 12.3% year-over-year to $113.22 billion, driven by growth in Optum and enrollment in UnitedHealthcare's government programs, but slightly below consensus expectations [5] - Adjusted EPS was approximately $2.11, meeting expectations, but underlying profitability weakened due to high medical utilization and care costs compressing insurance margins, particularly in Medicare Advantage [5] - The company incurred $1.6 billion in charges related to Optum portfolio realignment and business optimization, impacting reported earnings and segment margins [5] Analyst Expectations - For the current fiscal year ending in December, analysts project UNH's EPS to rise by 8.2% to $17.69 on a diluted basis [6] - UNH has a mixed earnings surprise history, beating consensus estimates in two of the last four quarters while missing forecasts in two others [6] - Among 26 analysts covering UNH stock, the consensus rating is a "Moderate Buy," with 16 "Strong Buy" ratings, two "Moderate Buys," seven "Holds," and one "Strong Sell" [6] - The analyst configuration has become more bullish, with 15 analysts now suggesting a "Strong Buy" [7]